EA Series Trust’s Elevance Health ELV Stock Holding History

EA Series Trust’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	$2.07M	Buy	+4,650	New	+$2.15M	0.07%	381

Other funds holding ELV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

EA Series Trust's ELV Position: Q2 2023 in Review

EA Series Trust opened a new position in Elevance Health (ELV) in Q2 2023: 4,650 shares worth $2.07M. The stake represents 0.07% of the portfolio and ranks #381 among its holdings.

1,523 funds tracked by Wall St. Rank hold ELV as of Q2 2023.

EA Series Trust held 4,650 shares of Elevance Health worth $2.07M as of Q2 2023.
Elevance Health was a new EA Series Trust position in Q2 2023.
Elevance Health made up 0.07% of EA Series Trust's portfolio in Q2 2023, its #381 holding.
1,523 funds tracked by Wall St. Rank held Elevance Health as of Q2 2023.

Based on EA Series Trust's 13F filing for Q2 2023, filed 27 Jul 2023.